<!DOCTYPE html>
<html lang="en">
<head>
  <meta charset="utf-8">

  <title>NICE Formulary - THIAZIDES AND RELATED DIURETICS</title>

  <meta name="X-UA-Compatible" content="IE=edge,chrome=1">
  <meta name="viewport" content="width=device-width, initial-scale=1.0, maximum-scale=1.0">
  <meta name="description" content="">
  <meta name="author" content="NICE - The National Institute of Health and Care Excellence">

  <!--[if lt IE 9]>
  <script src="http://mattonfoot.github.io/NICE.UI/scripts/vendor/html5shiv.js"></script>
  <![endif]-->

  <!-- Le styles -->
  <link rel="stylesheet" href="http://mattonfoot.github.io/NICE.UI/styles/ui.css">

  <!-- Fav and touch icons -->
  <link rel="shortcut icon" href="http://cdn.nice.org.uk/V3/Content/nice/favicon.ico">
  <link rel="apple-touch-icon-precomposed" href="http://cdn.nice.org.uk/V3/Content/nice/favicon-152.png">
  <meta name="msapplication-TileColor" content="#fafafb">
  <meta name="msapplication-TileImage" content="http://cdn.nice.org.uk/V3/Content/nice/favicon-144.png">

  <style>
  .tab-content {
    overflow: auto;
  }
  .tab-content > .tab-pane {
    display: none;
  }
  .tab-content > .active {
    display: block;
  }

  header .nav {
    list-style: decimal inside none;
  }
  header .nav > li {
    display: list-item;
  }
  header .nav > li > a {
    display: block;
    margin: 0;
    padding: 0;
    text-decoration: none;
    color: #01769d;
  }
  header .nav > li > a:hover,
  header .nav > li > a:focus,
  header .nav > li.active > a,
  header .nav > li.active > a:hover,
  header .nav > li.active > a:focus {
    outline: 0;
    color: #08455b;
    background: transparent;
    text-decoration: none;
  }
  header .nav > li > a:hover,
  header .nav > li > a:focus {
    text-decoration: underline;
  }

  [outputclass="title"],
  .title {
    font-size: 19px;
    font-size: 1.9rem;
    line-height: 24px;
    line-height: 2.4rem;
  }

  h3, h4, h5, h6, .title, [outputclass="title"] {
    margin-bottom: 0;
  }

  h1+p, h2+p, h3+p, h4+p, h5+p, h6+p, .title+p, [outputclass="title"]+p {
    margin-top: 0;
  }

  .doses {
    padding-left: 0;
    list-style: none;
  }
  .doses .dose {
    padding-left: 24px;
    padding-left: 2.4rem;
    margin-bottom: 6px;
    margin-bottom: .6rem;
  }
  .doses .adult {
    border-left: 7px solid #346e7f;
  }
  .doses .child {
    border-left: 7px solid #82176F;
  }

  /* DITA symbols */

  ph {
    color: #006;
  }

  tm::before {
    font-size: .8em;
    margin-left: -.2em;
    vertical-align: top;
  }
  tm[tmtype="reg"]::before {
    content: "\00ae";
  }
  tm[tmtype="copy"]::before {
    content: "\00a9";
  }
  tm[tmtype="trade"]::before {
    content: "\2122";
  }

  </style>
</head>

<body id="" class="">
  <header>
    <div class="container">
      <ul class="breadcrumb">
        <li><a href="../">Home</a> <span class="divider glyph-chevron-right"></span></li>
        <li class="active"><a href="../drugClass/">Drug classes</a></li>
      </ul>

      <h1>THIAZIDES AND RELATED DIURETICS</h1>

      <nav>
        <ul class="nav nav-list">

          <li><a href="#pregnancy" data-toggle="tab">Pregnancy</a></li>
          <li><a href="#hepaticImpairment" data-toggle="tab">Hepatic impairment</a></li>
          <li><a href="#renalImpairment" data-toggle="tab">Renal impairment</a></li>
          <li><a href="#contraindications" data-toggle="tab">Contra indications</a></li>
          <li><a href="#sideEffects" data-toggle="tab">Side effects</a></li>
          <li><a href="#cautions" data-toggle="tab">Cautions</a></li>
          <li><a href="#monitoringRequirements" data-toggle="tab">Monitoring requirements</a></li>
          <li><a href="#drugsInClass" data-toggle="tab">Drugs in class</a></li>
        </ul>
      </nav>

      <br/>
    </div>
  </header>

  <div class="container">
    <div class="tab-content">



      <section class="tab-pane" id="pregnancy">
        <h2>Advice when patient is pregnant</h2>

            <section class="generalInformation">
              <p>Thiazides and related diuretics should not be used to treat gestational hypertension. They may cause neonatal thrombocytopenia, bone marrow suppression, jaundice, electrolyte disturbances, and hypoglycaemia; placental perfusion may also be reduced. Stimulation of labour, uterine inertia, and meconium staining have also been reported.</p>
            </section>
      </section>

      <section class="tab-pane" id="hepaticImpairment">
        <h2>Advice regarding hepatic impairment</h2>

            <section class="generalInformation">
              <p>Caution in mild to moderate impairment.</p><p>Avoid in severe liver disease.</p><p>Hypokalaemia may precipitate coma in hepatic impairment, although hypokalaemia can be prevented by using a potassium-sparing diuretic.</p>
            </section>
            <section class="generalInformation">
              <p>There is an increased risk of hypomagnesaemia in alcoholic cirrhosis.</p>
            </section>
      </section>

      <section class="tab-pane" id="renalImpairment">
        <h2>Advice regarding renal impairment</h2>

        
            <section class="generalInformation">
              <p>Thiazides and related diuretics are ineffective if eGFR is less than 30&#8239;mL/minute/1.73&#8239;m<sup>2</sup> and should be avoided.</p><p>Metolazone remains effective if eGFR is less than 30&#8239;mL/minute/1.73&#8239;m<sup>2</sup> but is associated with a risk of excessive diuresis.</p>
            </section>
      </section>

      <section class="tab-pane" id="contraindications">
        <h2>Contra indications</h2>

          <ul>
            <li>Addison&#8217;s disease</li>
            <li>hypercalcaemia</li>
            <li>hyponatraemia</li>
            <li>refractory hypokalaemia</li>
            <li>symptomatic hyperuricaemia</li>
          </ul>
      </section>

      <section class="tab-pane" id="sideEffects">
        <h2>Known side effects</h2>

          <h3>General side effects</h3>
              <p>
                <strong>commonOrVeryCommon:</strong> Altered plasma-lipid concentrations, gout, hypercalcaemia, hyperglycaemia, hyperuricaemia, hypochloraemic alkalosis, hypokalaemia, hypomagnesaemia, hyponatraemia, metabolic and electrolyte disturbances, mild gastrointestinal disturbances, postural hypotension,
              </p>
              <p>
                <strong>uncommon:</strong> Agranulocytosis, blood disorders, impotence, leucopenia, thrombocytopenia,
              </p>
              <p>
                <strong>notKnown:</strong> Cardiac arrhythmias, dizziness, headache, hypersensitivity reactions, intrahepatic cholestasis, pancreatitis, paraesthesia, photosensitivity, pneumonitis, pulmonary oedema, severe skin reactions, visual disturbances,
              </p>
        
        
        
      </section>





      <section class="tab-pane" id="cautions">
        <h2>Cautions regarding administration</h2>

        <ul>
          <li>
            Diabetes
          </li>
          <li>
            gout
          </li>
          <li>
            hyperaldosteronism
          </li>
          <li>
            malnourishment
          </li>
          <li>
            nephrotic syndrome
          </li>
          <li>
            systemic lupus erythematosus
          </li>
        </ul>
        <ul>
          <li>
            <p>Hypokalaemia can occur with both thiazide and loop diuretics. The risk of hypokalaemia depends on the duration of action as well as the potency and is thus greater with thiazides than with an equipotent dose of a loop diuretic.</p><p>Hypokalaemia is dangerous in severe cardiovascular disease and in patients also being treated with cardiac glycosides. Often the use of potassium-sparing diuretics avoids the need to take potassium supplements.</p><p>In hepatic failure, hypokalaemia caused by diuretics can precipitate encephalopathy, particularly in alcoholic cirrhosis.</p><p>Potassium supplements or potassium-sparing diuretics are seldom necessary when thiazides are used in the routine treatment of hypertension.</p>
          </li>
          <li>
            <p>Lower initial doses of diuretics should be used in the elderly because they are particularly susceptible to the side-effects. The dose should then be adjusted according to renal function. Diuretics should not be used continuously on a long-term basis to treat simple gravitational oedema (which will usually respond to increased movement, raising the legs, and support stockings).</p>
          </li>
          <li>
            <p>Thiazides and related diuretics can exacerbate diabetes, gout, and systemic lupus erythematosus.</p>
          </li>
        </ul>
      </section>


      <section class="tab-pane" id="monitoringRequirements">
        <h2>Monitoring requirements</h2>

        
          <h3>Patient parameters</h3>
        
            <section class="patientParameters">
              <p>Electrolytes should be monitored, particularly with high doses and long-term use.</p>
            </section>
      </section>











      <section class="tab-pane" id="drugsInClass">
        <h2>Drugs in the class of THIAZIDES AND RELATED DIURETICS</h2>

          <ul>
            <li><a href="../drug/PHP107867.html">HYDROCHLOROTHIAZIDE</a></li>
            <li><a href="../drug/PHP780.html">BENDROFLUMETHIAZIDE</a></li>
            <li><a href="../drug/PHP785.html">CHLORTALIDONE</a></li>
            <li><a href="../drug/PHP788.html">CYCLOPENTHIAZIDE</a></li>
            <li><a href="../drug/PHP792.html">INDAPAMIDE</a></li>
            <li><a href="../drug/PHP799.html">METOLAZONE</a></li>
            <li><a href="../drug/PHP803.html">XIPAMIDE</a></li>
            <li><a href="../drug/PHP845.html">CO-AMILOZIDE</a></li>
            <li><a href="../drug/PHP983.html">CO-TENIDONE</a></li>
          </ul>
      </section>

    </div>
  </div>

  <script src="http://mattonfoot.github.io/NICE.UI/scripts/vendor/jquery.js"></script>
  <script src="http://cdn.nice.org.uk/V3/Scripts/twitter.bootstrap.js"></script>
</body>
</html>
